(Q37851950)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21395355%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

review article

1 reference

title

HIV vaccines: progress to date (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21395355%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

0 references

Cynthia Mee Ling Munier

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21395355%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Christopher R Andersen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21395355%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Anthony D Kelleher

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21395355%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

publication date

1 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21395355%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21395355%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21395355%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21395355%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

387-414

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21395355%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/11585400-000000000-00000

25 January 2020

exact match

0 references

cites work

The role of sexually transmitted diseases in HIV transmission

1 reference

12 December 2020

Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen

1 reference

12 December 2020

Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.

1 reference

12 December 2020

Innate immune responses in primary HIV-1 infection.

1 reference

12 December 2020

Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone

1 reference

12 December 2020

Constitutive expression of stromal derived factor-1 by mucosal epithelia and its role in HIV transmission and propagation.

1 reference

12 December 2020

HIV-1 Populations in Semen Arise through Multiple Mechanisms

1 reference

12 December 2020

Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1

1 reference

12 December 2020

The effects of protease inhibitor therapy on human immunodeficiency virus type 1 levels in semen (AIDS clinical trials group protocol 850).

1 reference

12 December 2020

Impact of preexisting vector immunity on the efficacy of adeno-associated virus-based HIV-1 Gag vaccines.

1 reference

12 December 2020

Humoral immunity to HIV-1: neutralization and beyond.

1 reference

12 December 2020

Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial

1 reference

12 December 2020

Cellular immune responses to HIV.

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand

1 reference

12 December 2020

Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome

1 reference

12 December 2020

A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding

1 reference

12 December 2020

Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals

1 reference

12 December 2020

Wide variation in the multiplicity of HIV-1 infection among injection drug users

1 reference

12 December 2020

Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection

1 reference

12 December 2020

Antibody neutralization and escape by HIV-1

1 reference

12 December 2020

Repeated low-dose mucosal simian immunodeficiency virus SIVmac239 challenge results in the same viral and immunological kinetics as high-dose challenge: a model for the evaluation of vaccine efficacy in nonhuman primates

1 reference

12 December 2020

A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge.

1 reference

12 December 2020

HIV-1-infected blood mononuclear cells form an integrin- and agrin-dependent viral synapse to induce efficient HIV-1 transcytosis across epithelial cell monolayer.

1 reference

12 December 2020

Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys

1 reference

12 December 2020

Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma

1 reference

12 December 2020

Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection

1 reference

12 December 2020

Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages

1 reference

12 December 2020

Viral dynamics of acute HIV-1 infection

1 reference

12 December 2020

Broadly neutralizing monoclonal antibodies 2F5 and 4E10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus SHIVBa-L

1 reference

12 December 2020

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

1 reference

12 December 2020

An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector

1 reference

12 December 2020

Antibody-dependent cell-mediated cytotoxicity against cells infected with the human immunodeficiency virus

1 reference

12 December 2020

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

1 reference

12 December 2020

cis Expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptor

1 reference

12 December 2020

Core structure of gp41 from the HIV envelope glycoprotein

1 reference

12 December 2020

An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses

1 reference

12 December 2020

Targeting early infection to prevent HIV-1 mucosal transmission.

1 reference

12 December 2020

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract

1 reference

12 December 2020

Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study

1 reference

12 December 2020

Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection.

1 reference

12 December 2020

HIV among injecting drug users: current epidemiology, biologic markers, respondent-driven sampling, and supervised-injection facilities

1 reference

12 December 2020

Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 Infection

1 reference

12 December 2020

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Vaginal transmission of SIV: assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks

1 reference

12 December 2020

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

1 reference

12 December 2020

Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells

1 reference

12 December 2020

Independent association of hygiene, socioeconomic status, and circumcision with reduced risk of HIV infection among Kenyan men

1 reference

12 December 2020

Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1

1 reference

12 December 2020

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

12 December 2020

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

1 reference

12 December 2020

Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells

1 reference

12 December 2020

Dendritic cells and HIV-specific CD4+ T cells: HIV antigen presentation, T-cell activation, and viral transfer

1 reference

12 December 2020

Transmission, acute HIV-1 infection and the quest for strategies to prevent infection

1 reference

12 December 2020

Contribution of the rev gene to the immunogenicity of DNA vaccines targeting the envelope glycoprotein of HIV

1 reference

12 December 2020

High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection

1 reference

12 December 2020

HIV vaccine research: the way forward

1 reference

12 December 2020

HIV binding, penetration, and primary infection in human cervicovaginal tissue

1 reference

12 December 2020

Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections

1 reference

12 December 2020

HIV-1 target cells in foreskins of African men with varying histories of sexually transmitted infections

1 reference

12 December 2020

Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade Bgag/pol/nefVaccine in Healthy Adults

1 reference

12 December 2020

Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies

1 reference

12 December 2020

The 2007 Estimates for People at Risk for and Living With HIV in China: Progress and Challenges

1 reference

12 December 2020

Determining seminal plasma human immunodeficiency virus type 1 load in the context of efficient highly active antiretroviral therapy.

1 reference

12 December 2020

Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees.

1 reference

12 December 2020

Molecular and Clinical Epidemiology of CXCR4‐Using HIV‐1 in a Large Population of Antiretroviral‐Naive Individuals

1 reference

12 December 2020

Ex vivo culture of human colorectal tissue for the evaluation of candidate microbicides

1 reference

12 December 2020

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

1 reference

12 December 2020

Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection

1 reference

12 December 2020

Enhancement of infectious disease vaccines through TLR9-dependent recognition of CpG DNA.

1 reference

12 December 2020

A new generation of animal cell expression vectors based on the Semliki Forest virus replicon

1 reference

12 December 2020

Evaluation in macaques of HIV-1 DNA vaccines containing primate CpG motifs and fowlpoxvirus vaccines co-expressing IFN? or IL-12

1 reference

12 December 2020

Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS

1 reference

12 December 2020

HIV vaccine design and the neutralizing antibody problem

1 reference

12 December 2020

Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier

1 reference

12 December 2020

CD8+ cells in human immunodeficiency virus type I pathogenesis: cytolytic and noncytolytic inhibition of viral replication.

1 reference

12 December 2020

Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity

1 reference

12 December 2020

Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study

1 reference

12 December 2020

Setting the stage: host invasion by HIV.

1 reference

12 December 2020

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector

1 reference

12 December 2020

Recombinant Virus Vaccine-Induced SIV-specific CD8 + Cytotoxic T Lymphocytes

1 reference

12 December 2020

Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity

1 reference

12 December 2020

Therapeutic vaccination with simian immunodeficiency virus (SIV)-DNA + IL-12 or IL-15 induces distinct CD8 memory subsets in SIV-infected macaques

1 reference

12 December 2020

Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS.

1 reference

12 December 2020

HIV Vaccines: A Global Perspective

1 reference

12 December 2020

Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus

1 reference

12 December 2020

Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine

1 reference

12 December 2020

Differential neutralization of human immunodeficiency virus (HIV) replication in autologous CD4 T cells by HIV-specific cytotoxic T lymphocytes

1 reference

12 December 2020

Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa

1 reference

12 December 2020

HIV preferentially infects HIV-specific CD4+ T cells

1 reference

12 December 2020

Sindbis virus: an efficient, broad host range vector for gene expression in animal cells

1 reference

12 December 2020

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

1 reference

12 December 2020

A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals

1 reference

12 December 2020

Construction, Rescue, and Characterization of Vectors Derived from Ovine Atadenovirus

1 reference

12 December 2020

Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro

1 reference

12 December 2020

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

12 December 2020

Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection

1 reference

12 December 2020

Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV disease

1 reference

12 December 2020

Decrease in HIV-1 seminal shedding in men receiving highly active antiretroviral therapy: an 18 month longitudinal study (ANRS EP012)

1 reference

12 December 2020

The enigma of dendritic cell-immunodeficiency virus interplay

1 reference

12 December 2020

Characterization of CD4(+) CTLs ex vivo

1 reference

12 December 2020

Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers

1 reference

12 December 2020

HIV infection of the genital mucosa in women.

1 reference

12 December 2020

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

1 reference

12 December 2020

Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.

1 reference

12 December 2020

Cytokine control of memory T-cell development and survival

1 reference

12 December 2020

Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen

1 reference

12 December 2020

Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

1 reference

12 December 2020

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

1 reference

12 December 2020

Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D

1 reference

12 December 2020

Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection

1 reference

12 December 2020

Identification of a major co-receptor for primary isolates of HIV-1

1 reference

12 December 2020

Assembly and morphology of HIV: potential effect of structure on viral function

1 reference

12 December 2020

Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus

1 reference

12 December 2020

Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies

1 reference

12 December 2020

Redox-Triggered Infection by Disulfide-Shackled Human Immunodeficiency Virus Type 1 Pseudovirions

1 reference

12 December 2020

Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV.

1 reference

12 December 2020

Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies.

1 reference

12 December 2020

A Phase II Study of Two HIV Type 1 Envelope Vaccines, Comparing Their Immunogenicity in Populations at Risk for Acquiring HIV Type 1 Infection

1 reference

12 December 2020

Genotypic and phenotypic characterization of HIV-1 patients with primary infection

1 reference

12 December 2020

Human immunodeficiency virus viral load in blood plasma and semen: review and implications of empirical findings

1 reference

12 December 2020

Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial

1 reference

12 December 2020

Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1.

1 reference

12 December 2020

Mucosal and systemic HIV-1 Env-specific CD8(+) T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector.

1 reference

12 December 2020

Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells

1 reference

12 December 2020

Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda

1 reference

12 December 2020

Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys

1 reference

12 December 2020

Dissemination of SIV after rectal infection preferentially involves paracolic germinal centers

1 reference

12 December 2020

Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm

1 reference

12 December 2020

Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge

1 reference

12 December 2020

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

1 reference

12 December 2020

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

1 reference

12 December 2020

Memory CD4(+) T cells are the earliest detectable human immunodeficiency virus type 1 (HIV-1)-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system

1 reference

12 December 2020

Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes

1 reference

12 December 2020

Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants

1 reference

12 December 2020

The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection

1 reference

12 December 2020

Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.

1 reference

12 December 2020

Efficacy of DNA and fowlpox virus priming/boosting vaccines for simian/human immunodeficiency virus

1 reference

12 December 2020

Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein

1 reference

12 December 2020

Relation between HIV viral load and infectiousness: a model-based analysis.

1 reference

12 December 2020

Development of an oral prime-boost strategy to elicit broadly neutralizing antibodies against HIV-1.

1 reference

12 December 2020

Sexual Transmission and Propagation of SIV and HIV in Resting and Activated CD4+ T Cells

1 reference

12 December 2020

Human immunodeficiency virus type 1 shedding pattern in semen correlates with the compartmentalization of viral Quasi species between blood and semen.

1 reference

12 December 2020

Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue

1 reference

12 December 2020

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

12 December 2020

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

1 reference

12 December 2020

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

1 reference

12 December 2020

Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection

1 reference

12 December 2020

Comparative investigation of Langerhans' cells and potential receptors for HIV in oral, genitourinary and rectal epithelia

1 reference

12 December 2020

Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells

1 reference

12 December 2020

Persistent immune responses induced by a human immunodeficiency virus DNA vaccine delivered in association with electroporation in the skin of nonhuman primates

1 reference

12 December 2020

Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection

1 reference

12 December 2020

Evidence for frequent reinfection with human immunodeficiency virus type 1 of a different subtype

1 reference

12 December 2020

Trivalent adenovirus type 5 HIV recombinant vaccine primes for modest cytotoxic capacity that is greatest in humans with protective HLA class I alleles

1 reference

12 December 2020

Circumcision and HIV transmission

1 reference

12 December 2020

Diversity of receptors binding HIV on dendritic cell subsets

1 reference

12 December 2020

Antibody domain exchange is an immunological solution to carbohydrate cluster recognition

1 reference

12 December 2020

SIV/HIV Nef recombinant virus (SHIVnef) produces simian AIDS in rhesus macaques

1 reference

12 December 2020

Langerin is a natural barrier to HIV-1 transmission by Langerhans cells

1 reference

12 December 2020

HIV and chemokines: ligands sharing cell-surface receptors

1 reference

12 December 2020

Inhibiting sexual transmission of HIV-1 infection

1 reference

12 December 2020

Role of antibody-dependent cell-mediated cytotoxicity in the efficacy of therapeutic anti-cancer monoclonal antibodies.

1 reference

12 December 2020

Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle

1 reference

12 December 2020

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis

1 reference

12 December 2020

Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1.

1 reference

12 December 2020

Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission.

1 reference

12 December 2020

Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection

1 reference

12 December 2020

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

1 reference

12 December 2020

Shedding of HIV-1 in the genital tract

1 reference

12 December 2020

Repeated intravaginal inoculation with cell-associated simian immunodeficiency virus results in persistent infection of nonhuman primates

1 reference

12 December 2020

CD127+CCR5+CD38+++ CD4+ Th1 effector cells are an early component of the primary immune response to vaccinia virus and precede development of interleukin-2+ memory CD4+ T cells

1 reference

12 December 2020

The antigenic structure of the HIV gp120 envelope glycoprotein

1 reference

12 December 2020

NYVAC: a highly attenuated strain of vaccinia virus

1 reference

12 December 2020

Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa

1 reference

12 December 2020

The immune geography of IgA induction and function

1 reference

12 December 2020

High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response

1 reference

12 December 2020

Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture

1 reference

12 December 2020

Antigenic specificity of antibody-dependent cell-mediated cytotoxicity directed against human immunodeficiency virus in antibody-positive sera

1 reference

12 December 2020

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine

1 reference

12 December 2020

An HIV vaccine--evolving concepts

1 reference

12 December 2020

Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosis

1 reference

12 December 2020

Vaccination of seronegative volunteers with a human immunodeficiency virus type 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of beta-chemokines

1 reference

12 December 2020

Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection.

1 reference

12 December 2020

Recombinant bacillus Calmette-Guérin as a potential vector for preventive HIV type 1 vaccines

1 reference

12 December 2020

Expression of AIDS virus envelope gene in recombinant vaccinia viruses

1 reference

12 December 2020

Mucosal immune responses in the genital tract of HIV-1-exposed uninfected women

1 reference

12 December 2020

Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses.

1 reference

12 December 2020

Fc receptor but not complement binding is important in antibody protection against HIV.

1 reference

12 December 2020

Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01

1 reference

12 December 2020

Activation of a dendritic cell-T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells

1 reference

12 December 2020

Defensins in innate antiviral immunity

1 reference

12 December 2020

A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1

1 reference

12 December 2020

HIV-1 entry and its inhibition

1 reference

12 December 2020

Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target

1 reference

12 December 2020

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

1 reference

12 December 2020

Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia

1 reference

12 December 2020

Persistent immune activation in HIV-1 infection is associated with progression to AIDS.

1 reference

12 December 2020

Early proliferation of CCR5(+) CD38(+++) antigen-specific CD4(+) Th1 effector cells during primary HIV-1 infection.

1 reference

12 December 2020

Human immunodeficiency virus-1 acquisition in genital mucosa: Langerhans cells as key-players

1 reference

12 December 2020

Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants

1 reference

12 December 2020

Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques.

1 reference

12 December 2020

Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection.

1 reference

12 December 2020

Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques

1 reference

12 December 2020

Potential HIV-1 target cells in the human penis

1 reference

12 December 2020

Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission

1 reference

12 December 2020

Identification of human immunodeficiency virus subtypes with distinct patterns of sensitivity to serum neutralization

1 reference

12 December 2020

In vivo replication capacity rather than in vitro macrophage tropism predicts efficiency of vaginal transmission of simian immunodeficiency virus or simian/human immunodeficiency virus in rhesus macaques.

1 reference

12 December 2020

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

1 reference

12 December 2020

HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites

1 reference

12 December 2020

Natural killer cell immune responses

1 reference

12 December 2020

Lessons from a multisite international trial in the Caribbean and South America of an HIV-1 Canarypox vaccine (ALVAC-HIV vCP1452) with or without boosting with MN rgp120.

1 reference

12 December 2020

Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women

1 reference

12 December 2020

Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.

1 reference

12 December 2020

Current concepts of HIV transmission

1 reference

12 December 2020

Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adults

1 reference

12 December 2020

Activity of alpha- and theta-defensins against primary isolates of HIV-1

1 reference

12 December 2020

Atomic structure of the ectodomain from HIV-1 gp41

1 reference

12 December 2020

A whole-genome association study of major determinants for host control of HIV-1

1 reference

12 December 2020

Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection

1 reference

12 December 2020

The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity

1 reference

12 December 2020

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

1 reference

12 December 2020

Cross-clade neutralizing antibody production against human immunodeficiency virus type 1 clade E and B' strains by recombinant Mycobacterium bovis BCG-based candidate vaccine

1 reference

12 December 2020

Variable fate of virus-specific CD4(+) T cells during primary HIV-1 infection

1 reference

12 December 2020

Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques

1 reference

12 December 2020

A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag.

1 reference

12 December 2020

HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors

1 reference

12 December 2020

Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells.

1 reference

12 December 2020

Selection on the human immunodeficiency virus type 1 proteome following primary infection

1 reference

12 December 2020

Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

1 reference

12 December 2020

Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants.

1 reference

12 December 2020

Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells

1 reference

12 December 2020

KIR/HLA pleiotropism: protection against both HIV and opportunistic infections

1 reference

12 December 2020

A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1.

1 reference

12 December 2020

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

1 reference

12 December 2020

Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS

1 reference

12 December 2020

Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity

1 reference

12 December 2020

The CCR5 and CXCR4 coreceptors--central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Association of strong virus-specific CD4 T cell responses with efficient natural control of primary HIV-1 infection

1 reference

12 December 2020

Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys

1 reference

12 December 2020

Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C.

1 reference

12 December 2020

High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men.

1 reference

12 December 2020

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

1 reference

12 December 2020

Genital mucosal transmission of simian immunodeficiency virus: animal model for heterosexual transmission of human immunodeficiency virus

1 reference

12 December 2020

Analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1-infected individuals

1 reference

12 December 2020

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants

1 reference

12 December 2020

Brief but efficient: acute HIV infection and the sexual transmission of HIV.

1 reference

12 December 2020

Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?

1 reference

12 December 2020

Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes

1 reference

12 December 2020

Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection

1 reference

12 December 2020

T-cell responses to human AIDS virus in macaques immunized with recombinant vaccinia viruses

1 reference

12 December 2020

Development of an in vitro organ culture model to study transmissionof HIV-1 in the female genital tract

1 reference

12 December 2020

High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors.

1 reference

12 December 2020

Sugar-binding proteins potently inhibit dendritic cell human immunodeficiency virus type 1 (HIV-1) infection and dendritic-cell-directed HIV-1 transfer

1 reference

12 December 2020

Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection

1 reference

12 December 2020

Kinetics of virus-specific CD8+ T cells and the control of human immunodeficiency virus infection

1 reference

12 December 2020

Reemergence of the HIV epidemic among men who have sex with men in North America, Western Europe, and Australia, 1996-2005.

1 reference

12 December 2020

Critical issues in mucosal immunity for HIV-1 vaccine development

1 reference

12 December 2020

DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells

1 reference

12 December 2020

Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells.

1 reference

12 December 2020

Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells

1 reference

12 December 2020

Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood

1 reference

12 December 2020

High-level primary CD8(+) T-cell response to human immunodeficiency virus type 1 gag and env generated by vaccination with recombinant vesicular stomatitis viruses

1 reference

12 December 2020

Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and immunogenicity

1 reference

12 December 2020

Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial

1 reference

12 December 2020

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

1 reference

12 December 2020

Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection

1 reference

12 December 2020

Identifiers

1 reference